Clinical trial
Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage…
NCT00227565 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00227565 |
|---|---|
| Title | Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
| Official title | Phase II Trial of Pemetrexed Disodium and Carboplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | carboplatin, pemetrexed disodium, radiation |
| Enrollment | 50 |
| Start date | Feb 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Oct 1, 2009 |
| First posted | Sep 28, 2005 |
| Last update posted | Jul 6, 2016 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: